Gapping up
In reaction to strong earnings/guidance:
- ADBE +4.3%, JBL +4.1%, X +2.1%, LUV +0.5% (guidance)
Other news:
- AXTA +16.2% (initiates comprehensive review of strategic alternatives)
- MCRB +5.7% (provides statement on a safety alert from the FDA regarding bloodstream infections with multi-drug resistant organisms transmitted through fecal microbiota transplantation)
- ARQL +3.1% (extending recent gains after confirming plans to present at the BMO Prescriptions for Success Healthcare Conference on June 25, 2019)
- AKS +1.8% (following X guidance)
- VIAB +1.3% (after late move higher on WSJ report that CBS is formulating a merger offer)
- STLD +0.7% (following X guidance)
Analyst comments:
- STM +3.8% (initiated with an Overweight at Morgan Stanley)
- TRIP +2% (upgraded to Buy from Hold at SunTrust)
- FNF +1.7% (initiated with a Positive at Susquehanna)
- UPWK +1.5% (initiated with Overweight at Cantor Fitzgerald)
- ASML +0.9% (initiated with an Overweight at Morgan Stanley)
- NCMI +0.7% (upgraded to Outperform from Neutral at Wedbush)